TARCEVA (Erlotinib) drug information from MPR
Links shared publicly online about this topic.
- 1,110total visits
TARCEVA (Erlotinib) drug information from MPR
empr.com —
TARCEVA (Erlotinib) drug information for Cancer, pancreatic, Neoplasms, Non-small cell lung cancer from MPR including side effects, drug interactions, dosing, contraindications and precautions.
View full resource at empr.com
Tags: Pancreatic Disease, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Drug, Tarceva
Most Recently Shared on June 8, 2010 at 4:22 am By:
MPR News: TARCEVA: Indications: approved as maintenance therapy for advanced non-small cell lung cancer. http://bit.ly/A3cw6
Advertisement
